Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Allele Traits01:49

Multiple Allele Traits

32.6K
The Concept of Multiple Allelism
32.6K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

3.4K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.4K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

13.6K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
13.6K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

64.4K
Overview
64.4K
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

14.3K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
14.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unsupervised Clustering for POAG Phenotyping.

Investigative ophthalmology & visual science·2026
Same author

Prehospital Application of Pelvic Binders for Suspected Pelvic Ring Injuries: A Retrospective Cohort Study.

Prehospital emergency care·2026
Same author

Radiation therapy causes a STING and MyD88-independent upregulation of CD80 and CD86 in macrophages and monocytes that limits tumor control.

Cancer immunology, immunotherapy : CII·2025
Same author

Recall by polygenic risk score in two biobanks supports a genomic approach for glaucoma detection.

Research square·2025
Same author

ST8Sia6 overexpression protects pancreatic β cells from spontaneous autoimmune diabetes in nonobese diabetic mice.

The Journal of clinical investigation·2025
Same author

The Impact of Vision Impairment on Self-Reported Falls Among Older US Adults: Cross-Sectional and Longitudinal Study.

JMIR aging·2025

Related Experiment Video

Updated: Apr 28, 2026

Generation of Human Alloantigen-specific T Cells from Peripheral Blood
09:47

Generation of Human Alloantigen-specific T Cells from Peripheral Blood

Published on: November 21, 2014

12.4K

Hemin controls T cell polarization in sickle cell alloimmunization.

Hui Zhong1, Weili Bao1, David Friedman2

  • 1Laboratory of Complement Biology, New York Blood Center, New York, NY 10065;

Journal of Immunology (Baltimore, Md. : 1950)
|June 1, 2014
PubMed
Summary

Patients with sickle cell disease (SCD) receiving transfusions may develop alloimmunization. Non-alloimmunized SCD patients’ monocytes promote an anti-inflammatory state, reducing alloimmunization risk.

More Related Videos

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

1.4K
Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

17.2K

Related Experiment Videos

Last Updated: Apr 28, 2026

Generation of Human Alloantigen-specific T Cells from Peripheral Blood
09:47

Generation of Human Alloantigen-specific T Cells from Peripheral Blood

Published on: November 21, 2014

12.4K
A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

1.4K
Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

17.2K

Area of Science:

  • Immunology
  • Hematology

Background:

  • Sickle cell disease (SCD) patients often need transfusions, risking alloimmunization.
  • Alloimmunization against transfused red blood cells (RBCs) causes serious complications.
  • Risk factors for alloimmunization in SCD are not fully understood.

Purpose of the Study:

  • To investigate how monocytes influence T cell polarization in response to hemin in alloimmunized versus non-alloimmunized SCD patients.
  • To test if monocyte responses to RBC breakdown products differ between SCD patient groups.

Main Methods:

  • Co-culturing T cells and monocytes from healthy volunteers and SCD patients with hemin.
  • Analyzing T cell polarization (Treg, Th1) and monocyte heme oxygenase-1 (HO-1) expression.
  • Measuring cytokine levels (IFN-γ, IL-12) in response to hemin stimulation.

Main Results:

  • Hemin induced regulatory T cell (Treg) polarization via monocyte heme oxygenase-1 (HO-1) in healthy controls.
  • Hemin induced an anti-inflammatory (higher Treg/lower Th1) state in non-alloimmunized SCD patients, primarily via CD16+ monocytes.
  • Alloimmunized SCD patients showed minimal T cell polarization changes with hemin, with higher IL-12 levels.
  • Non-alloimmunized SCD CD16+ monocytes had higher basal HO-1 and dampened IL-12 production.

Conclusions:

  • Non-alloimmunized SCD CD16+ monocytes, unlike those in alloimmunized patients, promote an anti-inflammatory environment in response to RBC breakdown products.
  • This monocyte-driven anti-inflammatory state may protect non-alloimmunized SCD patients from alloimmunization.
  • Monocyte function and response to hemin represent a potential therapeutic target to prevent transfusion-related alloimmunization in SCD.